NHS National Framework for Ferric Carboxymaltose injection
NHS England is establishing a national framework to supply ferric carboxymaltose injection across three regional lots. The framework runs from March 2027 for 15–23 months with possible extension up to 24 months.
- Closes29 September 2026
- Value£38m
- Per lot£13m across 3 lots
- BuyerNHS England
- WhereCentral and South West, North West and London & North, London South and North East
- CategoryHealth & medical
- RegionUK-wide
You'll want to look if you are a licensed pharmaceutical manufacturer or authorised distributor able to supply ferric carboxymaltose injection to NHS specifications across one or more of the regional lots.
Might not suit a small firm
- the contract itself is a large one
- it needs coverage across the whole UK